Brief: Rhoen Klinikum H1 EBITDA Down At EUR 35.5 Mln

Rhoen Klinikum AG

06/08/2020 06:09

Aug 6 (Reuters) - RHOEN KLINIKUM AG  RHKG.DE :
    * CONCLUDES THE FIRST SIX MONTHS OF 2020 WITH INCREASED
REVENUES -
HUGE CONTRIBUTION TOWARDS FIGHTING COVID-19 PANDEMIC - STRATEGIC
PARTNERSHIP WITH ASKLEPIOS
    * H1 REVENUE ROSE 4.1 PERCENT TO 670.5 MILLION EUR
    * GUIDANCE FOR 2020 SUBJECT TO COVID-19 EFFECTS: REVENUES IN
AMOUNT OF EURO 1.4 BILLION +/- 5 PERCENT; EBITDA IN A RANGE OF
EURO 72.5 MILLION TO EURO 82.5 MILLION
    * H1 EBITDA SANK TO EURO 35.5 MILLION FOLLOWING EURO 60.9
MILLION
IN SAME PERIOD LAST YEAR
    * H1 NET CONSOLIDATED PROFIT FELL TO EURO - 3.7 MILLION
AFTER EURO
20.5 MILLION IN FIRST SIX MONTHS OF 2019
    * TO PROPOSE TO ORDINARY ANNUAL GENERAL MEETING ON 19^TH
AUGUST
2020 TO REFRAIN FROM PAYING OUT A DIVIDEND FOR FINANCIAL YEAR
2019

Source text for Eikon:  ID:nEQ5ps3lNa 
Further company coverage:  RHKG.DE 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;;))